Stay updated with breaking news from Nasdaq Huma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Humacyte, Inc. (NASDAQ:HUMA – Get Free Report) saw strong trading volume on Wednesday after an insider bought additional shares in the company. 891,494 shares traded hands during trading, a decline of 25% from the previous session’s volume of 1,189,422 shares.The stock last traded at $6.65 and had previously closed at $6.42. Specifically, Director […]
Powell Investment Advisors LLC raised its stake in shares of Humacyte, Inc. (NASDAQ:HUMA – Free Report) by 75.0% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 21,000 shares of the company’s stock after purchasing an additional 9,000 shares during the period. Powell Investment […]
Piper Sandler reiterated their neutral rating on shares of Humacyte (NASDAQ:HUMA – Free Report) in a research note issued to investors on Tuesday morning, Benzinga reports. The brokerage currently has a $4.00 price objective on the stock. Several other equities research analysts also recently commented on HUMA. HC Wainwright started coverage on shares of Humacyte […]
Piper Sandler reaffirmed their neutral rating on shares of Humacyte (NASDAQ:HUMA – Free Report) in a report published on Tuesday morning, Benzinga reports. The brokerage currently has a $4.00 target price on the stock. HUMA has been the topic of several other reports. HC Wainwright assumed coverage on shares of Humacyte in a research report […]
Benchmark reiterated their buy rating on shares of Humacyte (NASDAQ:HUMA – Free Report) in a report published on Monday, Benzinga reports. They currently have a $15.00 price target on the stock. Separately, HC Wainwright assumed coverage on Humacyte in a report on Monday, December 11th. They issued a buy rating and a $6.00 target price […]